Page last updated: 2024-09-05

sodium glutamate and Carcinoma 256, Walker

sodium glutamate has been researched along with Carcinoma 256, Walker in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akamine, EH; de Carvalho, MH; de Queiroz, EA; Fortes, ZB; Sampaio, SC1
Agostinho, AR; Barella, LF; Beraldi, EJ; de Castro Prado, MA; de Oliveira, JC; de Sant'Anna, JR; de Souza, CO; de Souza, HM; Franco, CC; Gravena, C; Malta, A; Mathias, PC; Miranda, RA; Prates, KV; Tófolo, LP; Torrezan, R; Trombini, AB1

Other Studies

2 other study(ies) available for sodium glutamate and Carcinoma 256, Walker

ArticleYear
Metformin reduces the Walker-256 tumor development in obese-MSG rats via AMPK and FOXO3a.
    Life sciences, 2015, Jan-15, Volume: 121

    Topics: Animals; Carcinoma 256, Walker; Cyclic AMP-Dependent Protein Kinases; Female; Food Additives; Forkhead Box Protein O3; Forkhead Transcription Factors; Hypoglycemic Agents; Male; Mammary Neoplasms, Experimental; Metformin; Obesity; Rats; Rats, Wistar; Signal Transduction; Sodium Glutamate

2015
Protective effect of metformin against walker 256 tumor growth is not dependent on metabolism improvement.
    Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, 2014, Volume: 34, Issue:6

    Topics: Animals; Blood Glucose; Carcinoma 256, Walker; Cell Proliferation; Diabetes Mellitus, Experimental; Glucose Intolerance; Hypoglycemic Agents; Insulin; Insulin Resistance; Islets of Langerhans; Metformin; Neoplasms; Rats; Sodium Glutamate

2014